HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Skin cancer in Australian heart transplant recipients.

AbstractBACKGROUND:
Cutaneous malignancy is a major cause of morbidity in organ transplant recipients.
OBJECTIVE:
Our purpose was to report on skin cancer in Australian heart transplant recipients with analysis of HLA factors.
METHODS:
We reviewed histologically proven skin cancers in the first 455 patients undergoing organ transplantation in Sydney, Australia.
RESULTS:
The cumulative incidence of skin cancer was 31% at 5 years and 43% at 10 years with a squamous cell carcinoma/basal cell carcinoma ratio of 3:1. Caucasian origin, increasing age at transplantation, and duration of follow-up were significantly associated with skin cancer. Skin cancer accounted for 27% of 41 deaths occurring after the fourth year. Recipient HLA-DR homozygosity was associated with skin cancer overall, whereas HLA-DR7 was a protective factor in skin cancer overall, squamous cell carcinoma, and Bowen's disease. HLA-A1 and HLA-A11 were significant protective factors in Bowen's disease.
CONCLUSION:
Skin cancer is a major cause of morbidity and long-term mortality in heart transplant patients.
AuthorsC S Ong, A M Keogh, S Kossard, P S Macdonald, P M Spratt
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 40 Issue 1 Pg. 27-34 (Jan 1999) ISSN: 0190-9622 [Print] United States
PMID9922009 (Publication Type: Journal Article)
Chemical References
  • HLA Antigens
  • HLA-DR Antigens
Topics
  • Australia (epidemiology)
  • Carcinoma, Basal Cell (epidemiology)
  • Carcinoma, Squamous Cell (epidemiology)
  • Female
  • Follow-Up Studies
  • HLA Antigens (analysis, genetics)
  • HLA-DR Antigens (genetics)
  • Heart Transplantation (statistics & numerical data)
  • Homozygote
  • Humans
  • Immunosuppression Therapy
  • Incidence
  • Logistic Models
  • Male
  • Middle Aged
  • Morbidity
  • Postoperative Complications (epidemiology)
  • Retrospective Studies
  • Risk Factors
  • Skin Neoplasms (epidemiology)
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: